Overview Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation Status: Completed Trial end date: 2014-06-01 Target enrollment: Participant gender: Summary The purpose of this study is to investigate the effect of switching participants taking levothyroxine to a new sodium formulation. Phase: Phase 2 Details Lead Sponsor: Takeda